Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8-C Study in Chronic Low Back Pain Patients
New real-world evidence further supports the efficacy and use of ReActiv8 Restorative Neurostimulation for the treatment of intractable Chronic Low Back Pain Mainstay Medical Holdings plc today announced
Source: finanznachrichten.de